The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 19, 2017
Filed:
Dec. 21, 2012
Applicants:
Innate Pharma, Marseilles, FR;
Paul Scherrer Institut, Villigen PSI, CH;
Inventors:
Patrick Dennler, Wettingen, CH;
Delphine Bregeon, Marseilles, FR;
Laurent Gauthier, Marseilles, FR;
François Romagné, Marseilles, FR;
Christian Belmant, Six-Fours-les-Plages, FR;
Eliane Fischer, Eglisau, CH;
Roger Schibli, Baden, CH;
Assignees:
INNATE PHARMA, Marseilles, FR;
PAUL SCHERRER INSTITUT, Villigen, CH;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/48 (2006.01); C07K 16/18 (2006.01); C07K 16/22 (2006.01); C07K 16/28 (2006.01); C07K 16/30 (2006.01); C07K 16/00 (2006.01); C07K 19/00 (2006.01); C07C 217/08 (2006.01); C07C 223/02 (2006.01); C07C 229/26 (2006.01); C07C 233/62 (2006.01); C07C 247/04 (2006.01); C07C 323/12 (2006.01); C07C 323/60 (2006.01); C07D 225/08 (2006.01); C07D 257/08 (2006.01); C07D 277/06 (2006.01); C07F 9/50 (2006.01); C12N 9/10 (2006.01); C12P 21/00 (2006.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
A61K 47/48369 (2013.01); A61K 47/48215 (2013.01); A61K 47/48384 (2013.01); A61K 47/48623 (2013.01); A61K 47/48646 (2013.01); C07C 217/08 (2013.01); C07C 223/02 (2013.01); C07C 229/26 (2013.01); C07C 233/62 (2013.01); C07C 247/04 (2013.01); C07C 323/12 (2013.01); C07C 323/60 (2013.01); C07D 225/08 (2013.01); C07D 257/08 (2013.01); C07D 277/06 (2013.01); C07F 9/5022 (2013.01); C07K 16/00 (2013.01); C07K 19/00 (2013.01); C12N 9/1044 (2013.01); C12P 21/005 (2013.01); G01N 33/6854 (2013.01); C07K 2317/40 (2013.01);
Abstract
The present application relates to methods for the functionalization of immunoglobulins, in particular with drugs. Also disclosed herein are linking reagents, functionalized antibodies, pharmaceutical compositions, and method of treating disease and/or conditions.